Predictive value of umbilical cord blood bilirubin in neonatal hyperbilirubinemia  by Zeitoun, AlaaEldin A. et al.
Egyptian Pediatric Association Gazette (2013) 61, 23–30Contents lists available at SciVerse ScienceDirect
Egyptian Pediatric Association Gazette
journal homepage: http://ees.elsevier.com/epagFULL LENGTH ARTICLEPredictive value of umbilical cord blood bilirubin
in neonatal hyperbilirubinemiaAlaaEldin A. Zeitoun a, Hala F. Elhagrasy a,*, Doaa M. Abdelsatar ba Pediatric Department, Faculty of Medicine, Suez Canal University, Egypt
b Pediatric Department, Ismailia General Hospital, EgyptReceived 6 May 2012; accepted 2 June 2012
Available online 4 June 2013* Corresponding author. Tel.
E-mail address: dr_pedia7@h
Peer review under responsibility
Production an
1110-6638 ª 2013 Production
http://dx.doi.org/10.1016/j.epag: +20 97
otmail.co
of The E
d hostin
and hosti
.2013.04Abstract Introduction: Jaundice is a clinical condition that is often present in pediatric practice and
constitutes one of the major issues within the neonatal period. It occurs in both the physiological and
pathological processes in newborns.1 Although most newborns with jaundice are otherwise healthy,
they need to be monitored because bilirubin is potentially toxic to the central nervous system.2 The
American Academy of Pediatrics (AAP) in 2004 recommended that newborns discharged within
48 h should have follow up visits after 2–3 days to detect signiﬁcant jaundice.3
Aim of the work: This study was done to evaluate the predictive value of umbilical cord bilirubin in
identifying infants for subsequent hyperbilirubinemia, in full-term (FT) and late pre-term (PT) new-
borns.
Subjects andmethods: This study is a prospective clinical studywhichwas carried out on 94 newborns
taken from the delivery room (DR) and neonatal intensive care unit (NICU) of Ismailia General Hos-
pital at Ismailia Governorate. The study population was followed up clinically and by laboratory
investigations from birth and daily during the ﬁrst week of life.
Results: The study population consisted of 50 males and 44 females with the mean gestational age of
38.70 ± 1.38 weeks in FT compared to 35.62 ± 0.64 in late PT. It was shown that 40.4% of PT
needed treatment in the form of phototherapy compared to 29.8% of FT, and no one of both groups
needed exchange transfusion. The mean total cord bilirubin was higher among males, preterm, cesar-
ean deliveries, and ABO and RH incompatibility positive newborns. It was found that when cord
blood in late PT newborns was P1.75 mg/dl and P1.85 mg/dl in FT newborns, there was a
probability that those newborns may need phototherapy and when the levels of total cord bilirubin1507522712.
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24 A.A. Zeitoun et al.wereP2.05 mg/dl in PT newborns andP2.15 mg/dl in FT it means that those babies are in actual
need of phototherapy. Thus the cut-off points for total cord bilirubin level in PT and FT groups were
2.05 and 2.15 mg/dl respectively.
Conclusion: It was concluded that total serum bilirubin in cord blood was indicative of the jaundice
severity developed by healthy FT and late PT newborns without complications, during the ﬁrst week
of life.
Recommendations: Cord blood bilirubin could be a useful indicator of developing jaundice in new-
borns and the use of cut off cord bilirubin levels could be a useful predictor of signiﬁcant hyperbil-
irubinemia.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric Association.Introduction
Jaundice is the most common condition that requires medical
attention in newborns. 1 Neonatal jaundice may have ﬁrst been
described in a Chinese textbook 1000 years ago. Medical theses,
essays, and textbooks from the 18th and 19th centuries contain
discussions about the causes and treatment of neonatal jaun-
dice. 2 Neonatal hyperbilirubinemia is extremely common be-
cause almost every newborn develops an unconjugated serum
bilirubin level of more than 30 lmol/L (1.8 mg/dL) during
the ﬁrst week of life. 3 Jaundice is observed during the ﬁrst week
of life in approximately 60% of term infants and 80% of pre-
term infants.4
Early discharge of healthy term newborns after delivery has
become a common practice because of medical, social and eco-
nomical reasons. The most common cause for readmission dur-
ing the early neonatal period is hyperbilirubinemia. Such
readmission, besides involving extra expenses for both family
and the institution and also exposing a probably healthy new-
born to the hospital environment, brings emotional problems
and risks to breast-feeding, and is one of the causes of early
weaning.5
Concern regarding early discharge andhyperbilirubinemia in
newborns has led to frequent discussions and many controver-
sies. Early hospital discharge has had the implication of reexam-
ining the approach toward neonatal jaundice, now taking into
consideration the bilirubin levels presented in the ﬁrst 24–48 h
of life as a means of predicting severe hyperbilirubinemia. Thus,
the investigation of parameters that might help the physician
prevent the occurrence of severe hyperbilirubinemia is duly
justiﬁable.6
In recent years many efforts have been made to identify in-
fants likely to develop neonatal jaundice. Reliable strategies
can reduce hospital stay for normal babies and identify signif-
icant hyperbilirubinemia that may happen in the future. Uni-
versal follow-up within 1–2 days of early discharge, umbilical
cord bilirubin concentration at birth, routine pre-discharge
serum bilirubin and transcutaneous bilirubin measurement,
as well as the universal clinical assessment of risk factors of
developing jaundice are various strategies to predict signiﬁcant
hyperbilirubinemia.7
So that, it would be desirable to be able to predict the risk
of jaundice in order to implement early treatment and thereby
minimize the risk of bilirubin dependent brain damage. The
present study was conducted to evaluate the predictive value
of cord bilirubin level for identifying infants for subsequent
hyperbilirubinemia.Study objective
The aim of this study is to evaluate the predictive value of
umbilical cord bilirubin in identifying infants for subsequent
hyperbilirubinemia, in full-term and late pre-term neonates.Subjects and methods
Study design: It is a prospective clinical study carried out on all
neonates who developed hyperbilirubinemia during their ﬁrst
week of life.
Study site: the study was carried out at the delivery room
and neonatal intensive care unit (NICU) of Ismailia General
Hospital in Ismailia Governorate.
Study population: This study was carried out on 94 new-
borns (47 each in FT and late PT groups) with the following
criteria:
Inclusion criteria:
(1) Sequentially born, any type of delivery, both genders.
(2) Full term (gestational age is 37 weeks or more).
(3) Late preterm (Gestational age >34 weeks and
<37 weeks).
(4) APGAR score of over 7 at the ﬁrst minute and 10 at ﬁfth
minute of life.
(5) Absence of signiﬁcant illness or of major congenital
malformation.
Exclusion criteria
(1) Signiﬁcant illness (sepsis, RDS, asphyxia, IDM) that
could aggravate hyperbilirubinemia
(2) Gestational age <34 weeks
(3) Birth weight below 2000 gm.
Both study groups were followed up clinically and by labo-
ratory investigation from birth and daily during the ﬁrst week
of life.
All the study population was subjected to the following
baseline assessment for each newborn by history, physical
examination and investigations.
History included sex, type of delivery, detailed prenatal and
natal history, gestational age, blood groups, and family history
of neonatal jaundice.
Physical examination included APGAR score, anthropo-
metric measurements, skin color, presence of bruises or
Table 1 Distribution of newborns according to gender and
mode of delivery.
Characteristics FT No. (%) PT No. (%) Total No. (%)
Male 26 (55.3) 24 (51.15) 50 (53.2)
Female 21 (44.7) 23 (48.9) 44 (46.8)
NSVD 23 (48.9) 28 (59.65) 51 (54.3)
CS 24 (51.1) 19 (40.45) 43 (45.7)
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lard Score),8 and reﬂexes (Moro and suckling)
Laboratory investigations included: total serum bilirubin
TSB in the umbilical cord blood at birth and in the serum of
babies who develop signiﬁcant hyperbilirubinemia that need
treatment, complete blood count, serum albumin and investi-
gations for hemolysis; (reticulocyte count, direct Combs test,
and blood grouping for mothers and newborns).
Follow up of the degree of jaundice in those babies was car-
ried out daily during the ﬁrst week of life by transcutaneous
bilirubinometry (Bilicheck), which works by directing the
white light into the skin and measures the intensity of the spe-
ciﬁc wavelengths returned.9
Laboratory work
Three milliliters of cord venous blood was drained by a sterile
syringe, put in clean capped tube, and then sent immediately to
the Laboratory of the hospital. Serum was used, samples were
protected from light during processing and storage and hemo-
lyzed samples were excluded.9
Methods of assay of serum bilirubin
Total serum bilirubin, conjugated bilirubin and unconjugated
bilirubin were obtained via the colorimetric Diazo method.Table 2 Comparison of laboratory parameters between FT and PT
Parameter FT (n= 47) mean ± (SD)
HB (g/dl) 16.27 ± 0.87
TLC 13.77 ± 1.55
Neutrophil 55.47 ± 0.96
Retics 3.83 ± 1.44
Albumin (g/dl) 3.50 ± 0.29
TLC= Total Leukocytic count.
* Statistically signiﬁcant at p< 0.05 and 95% conﬁdence level.
Table 3 The mean transcutaneous bilirubin of study groups.
Day of measurement FT mean ± SD
Day 1 3.6 ± 1.14
Day 2 6.02 ± 2.04
Day 3 8.99 ± 3.48
Day 4 9.87 ± 5.35
Day 5 7.41 ± 5.62
Day 6 7.25 ± 5.41
Day 7 6.92 ± 5.18Ethical considerations
The study was approved by the research ethics committee of
faculty of Medicine, Suez Canal University. An informed con-
sent was taken from parents of the studied newborns before
taking any data or doing any investigations.
Data management and statistical analysis
The analysis was carried out using the statistical package for
the social sciences (SPSS) program for windows (SPSS Inc.,
Chicago, version 15.0) and p values with signiﬁcance of less
than 0.05 were considered statistically signiﬁcant.
Results
The study involved 94 newborns, 47 FT and 47 late PT, who
presented to the delivery room, and NICU of Ismailia general
Hospital.
Table 1 shows that the study population consisted of more
boys than girls and more NSVD than CS.
Regarding the gestational age of the study population it
was 38.70 ± 1.38 weeks in FT compared to 35.62 ± 0.64 in
PT. On the other hand, the mean birth weight was
2.94 ± 0.32 kg in FT compared to 2.52 ± 0.51 kg in PT, with
no signiﬁcant difference in both gestational age and birth
weight.
Table 2 shows that the mean hemoglobin level, the mean
TLC and neutrophil count were signiﬁcantly higher among
PT compared to FT. However there was no statistically signif-
icant difference between PT and FT regarding the mean albu-
min level and retics count.
Table 3 shows the effect of gestational age and day of mea-
surement of transcutaneous bilirubin. There was no statisti-
cally signiﬁcant difference in the mean of transcutaneous.
PT (n= 47) mean ± (SD) p-Value
16.89 ± 0.84 0.001*
14.52 ± 1.35 0.013*
56.23 ± 0.95 <0.001*
4.21 ± 1.48 0.204
3.50 ± 0.25 0.97
PT mean ± SD p-Value
3.6 ± 1.25 0.952
6.35 ± 2.43 0.470
8.34 ± 3.64 0.375
8.79 ± 5.26 0.329
7.91 ± 6.03 0.674
6.45 ± 5.70 0.487
5.84 ± 5.34 0.322
Figure 1 Comparison of time of the mean transcutaneous measurement during the ﬁrst 7 days of life.
Figure 2 Correlation between the mean cord bilirubin and total serum bilirubin.
26 A.A. Zeitoun et al.bilirubin between FT and PT babies at any time of
measurement.
Fig. 1 shows that the peak level of transcutaneous bilirubin
in either FT or PT babies was on day 4 of life.Fig. 2 shows that there was a signiﬁcant association be-
tween total bilirubin in cord blood and the newborn’s total
bilirubin level (r= 0.778; p< 0.001)
Table 4 Distribution of ABO and RH incompatibility among
the study population.
Incompatibility Positive No. (%) Negative No (%)
ABO 13 (13.8) 81 (86.2)
RH 3 (3.2) 91 (96.8)
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it was found that 40.4% of PT and 29.8% of FT needed pho-
totherapy and no one of both groups needed exchange
transfusion.
Table 4 shows that the ABO incompatibility was more com-
mon than RH incompatibility in all study population
As shown in Table 5, it was found that total and direct cord
bilirubin were slightly higher among FT compared to PT ba-
bies. However these differences were not signiﬁcant.
Table 6 shows the three cut-off points for total cord biliru-
bin test at which we can predict the need for phototherapy in
PT. The positive likelihood ratio is computed for each cut-off
point as sensitivity/1-speciﬁcity. A high positive likelihood ra-
tio is more important for a diagnostic test than for a screening
test. Receiver operating characteristic (ROC) curves in Fig. 4
show that, the area under the curve was 0.98 of total area,
p< 0.001, indicating the usefulness of the test in predicting
the need for phototherapy.
ROC curves in Fig. 3 show that, the area under the curve
was 0.98 of the total area; p< 0.001, indicating the usefulness
of the test in predicting the need for phototherapy.
Table 7 shows the three cut-off points for total cord biliru-
bin test at which we can predict the need for phototherapy in
FT. The positive likelihood ratio is computed for each cut-off
point as sensitivity/1-speciﬁcity. A high positive likelihood ra-
tio is more important for a diagnostic test than for a screening
test. ROC curves in Fig. 4 show that, the area under the curve
was 0.95 of total area, p, 0.001, indicating the usefulness of the
test in predicting the need for phototherapy.
ROC curves in (Fig. 4) shows that, the area under the curve
was 0.95 of the total area; p< 0.001, indicating the usefulness
of the test in predicting the need for phototherapy.Table 5 Comparison between mean total cord bilirubin in
both study groups.
Cord bilirubin FT mean ± SD PT mean ± SD p-Value
Total (mg/dl) 1.75 ± 0.41 1.72 ± 0.50 0.77
Direct (mg/dl) 0.35 ± 0.41 0.32 ± 0.50 0.81
Table 6 Cut-off points and diagnostic utility of total cord bilirubin
Purpose Cut-oﬀ value (mg/dl) Sensitivity (955 C
Screening 1.75 100.0(80.0, 120.0
Optimal 1.85 89.5(81.4, 98.6)
Diagnostic 2.05 68.4(54.7, 81.3)
Pvp = predictive value positive.
Pvn = predictive value negative.Direct logistic regression was performed to assess the im-
pact of a number of factors on the likelihood that newborns
would receive phototherapy. The model contained ﬁve inde-
pendent variables (gestational age, ABO incompatibility, Rh
incompatibility, Cord total bilirubin and highest total serum
bilirubin). The full model containing all predictors was statis-
tically signiﬁcant, v2 (5, N = 94) = 98.28, p< 0.001, indicat-
ing that the model was able to distinguish between newborns
who received and didn’t receive phototherapy. The model as
a whole explained between 64.8% and 89.3% of the variance
in receiving phototherapy, and correctly classiﬁed 92.6% of
cases. As shown in Table 8, four independent variables made
a statistically signiﬁcant contribution to the model. The stron-
gest predictor of receiving phototherapy was cord total biliru-
bin, recording an odds ratio of 33.08.
Discussion
Jaundice is a clinical condition that is often present and consti-
tutes one of the major issues during the neonatal period10.
The problem is that the prediction of jaundice becomes
more difﬁcult. Severe jaundice, and even kernicterus, can occur
in some full-term healthy newborns with no apparent hemo-
lytic, jaundice in the ﬁrst 24 h, or any causes other than breast-
feeding hyperbilirubinemia.5
In this study we investigated the correlation between level
of cord blood bilirubin and development of hyperbilirubine-
mia in the ﬁrst week of life. The study population consisted
of 50 (53.2%) males and 44 (46.8%) females. In the PT group
the mean total cord bilirubin was statistically signiﬁcantly
higher among males compared to females while in FT, the
mean total cord bilirubin was nearly equal among males and
females and there was no statistically signiﬁcant difference be-
tween them. This matched with the results of Amar et al. and
Rostami and Mehrabi10,7, but disagreed with the results of
Rudy et al.11 which showed that conjugated and unconjugated
bilirubin level in cord blood was signiﬁcantly different between
both sexes. This difference between both sexes may be due to
increased incidence of G6PD enzyme deﬁciency among males
as it is X linked recessive disorder.
We found that the mean gestational age of all newborns
was 38.70 ± 1.38 weeks in full terms compared to
35.62 ± 0.64 in preterm. Our results showed that there was a
signiﬁcant negative correlation between total cord bilirubin
and gestational age in the preterm group, while there was an
insigniﬁcant positive correlation in full terms. Matthias
et al.12, stated that the umbilical cord bilirubin is strongly neg-
atively correlated with gestational age, while the results of
Adelia and Canceicao5, whose studies were done on full terms
weighting >3.5 Kg showed no signiﬁcant correlation betweentest for identifying the need for phototherapy in PT.
I) Speciﬁcity (95% CI) Pvp Pvn
) 85.7(76.1, 95.9) 100.0 85.7
89.3(80.1, 97.9) 89.5 89.3
96.4(90.4, 101.6) 86.4 96.4
Figure 3 ROC curves for total cord bilirubin test in PT.
Figure 4 ROC curves for total cord bilirubin test in FT.
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weight newborns are more likely to develop hyperbilirubine-
mia because of immaturity of the liver with low levels of ligand
in hepatocytes, and low activity of bilirubin conjugating en-
zyme uridine diphoglucuronyltransferase(UDPGT), which
cause a decreased excretory capacity of the liver cells.
Regarding the mode of delivery and its relation to cord bil-
irubin there was no signiﬁcant difference between the normaldelivery group and the cesarean section group, and this result
matched with the results of Rostami and Mehrabi and Amar
et al.7,10, who stated that type of delivery did not affect the
umbilical cord bilirubin level.
Our study showed that 40.4% of preterm needed treatment
in the form of phototherapy compared to 29.8% of full term.
The mean total cord bilirubin for babies who received photo-
therapy was 2.19 ± 0.24 mg/dl which is signiﬁcantly higher
Table 7 Cut-off points and diagnostic utility of total cord bilirubin test for identifying the need for phototherapy in FT babies.
Purpose Cut-oﬀ value (mg/dl) Sensitivity (95%CI)100.0 (80.0,120.0) Speciﬁcity (955CI) PVP PVN
Screening 1.85 85.7 (76.1, 95.9) 81.8 (71.0, 92.9) 100.0 81.8
Optimal 1.95 50.0 (35.7, 64.3) 87.9 (78.7, 97.3) 85.7 87.9
Diagnostic 2.15 50.0(35.7, 64.3) 97.0 (92.1, 101.8) 50.0 97.1
Table 8 Logistic regression predicting the likelihood of receiving phototherapy.
Variable predictors B SE Wald df p-Value Odds ratio 95.0% C.I for Odds ratio Lower upper
Gestational age 4.08 1.81 5.07 1 0.02 59.31 1.697 2.07
ABO incompatibility 4.95 2.09 5.59 1 0.02 0.01 0.00 0.43
Rh incompatibility 13.82 2.11 0.00 1 0.99 0.00 0.00 0.00
Total cord bilirubin 15.01 5.74 6.84 1 0.01 33.08 43.11 253.9
Sex 1.88 0.762 6.08 1 0.01 6.55 1.47 29.20
Constant 43.17 2.11 0.000 1 0.99 0.00
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These results agreed with the results of Adelia and Canccicao,
2004 who found that phototherapy was signiﬁcantly associated
with higher levels of unconjugated bilirubin in cord blood as
the mean unconjugated bilirubin in cord blood for children
who received phototherapy was 2.12 ± 0.46 mg/dl and for
those who did not receive phototherapy was 1.75 ± 0.46 mg/
dl.5 Also Amar et al.10, showed that total cord blood was sig-
niﬁcantly higher in newborns who developed signiﬁcant hyper-
bilirubinemia after 72 h of age, which means that cord
bilirubin could be a useful indicator of risk of icterus in
newborns.
Our study showed that ABO incompatibility was found in
13.8% of all study groups and 3.2% only with RH incompat-
ibility. The mean total cord bilirubin was signiﬁcantly higher
among ABO positive babies compared to negative ones in both
groups. These results did not agree with the results of Adalia
and Canceicao5, which showed that there was no signiﬁcant
difference in cord bilirubin between babies with and without
maternal fetal blood incompatibility
In accordance with this, the study group was classiﬁed into
two groups, who required phototherapy and who did not re-
quire it, which is related to the levels of cord blood bilirubin
as follows: when cord bilirubin in preterm was P1.75 mg/dl
and P1.85 mg/dl in full terms, there was a probability that
those newborns may need phototherapy and when the levels
were P2.05 mg/dl in preterm and P2.15 mg/dl in full terms
means that those babies will actually need phototherapy.
Thus, by ROC analysis the cut-off points for total cord bil-
irubin in preterm and full term groups were 2.05 and 2.15 mg/
dl respectively. Rudy et al.11 determined using ROC analysis
that total bilirubin level in cord blood of >2.54 mg/dl had
high sensitivity and speciﬁcity. Amar et al.10, found that cord
bilirubin >2 mg/dl had the highest sensitivity and this critical
bilirubin level had a very high negative predictive value and
fairly low positive predictive value. According to these ﬁnd-
ings, a critical cut off level of cord bilirubin was 2 mg/dl pre-
dicted 90% of newborns who developed jaundice. However,
cord bilirubin level < 2 mg/dl did not completely exclude the
development of signiﬁcant hyperbilirubinemia.Rostami and Mehrabi,7 found that cord bilirubin above
3 mg/dl is not a useful predictor of jaundice and they con-
cluded that cord bilirubin cannot identify newborns with
subsequent signiﬁcant hyperbilirubinemia. In comparison to
these results Suresh and Clark,13 found that cord bilirubin
could predict the development of hyperbilirubinemia in
healthy term newborns. This study showed that bilirubin
critical level of >2 mg/dl had positive predictive value for
detection of developing signiﬁcant hyperbilirubinemia.
Another study done by Rataj et al.14 showed that critical le-
vel in cord blood >2.5 mg/dl had probability of 89% for
the development of signiﬁcant hyperbilirubinemia in
newborns.Summary and conclusion
The present study was conducted to evaluate the predictive
(cut-off) values of umbilical cord bilirubin in identifying in-
fants for subsequent hyperbilirubinemia, in full term and pre-
term babies.
The study was carried out on 94 healthy newborns (47 FT
and 47 PT) from the obstetrics department and NICU of Isma-
ilia General Hospital. Babies were chosen according to speciﬁc
inclusion and exclusion criteria.
The study group was followed up clinically and by labora-
tory investigations: total serum bilirubin in umbilical cord was
measured at birth, and followed up using transcutaneous bili-
rubinometry during the ﬁrst week of life to ﬁnd out babies
developing signiﬁcant hyperbilirubinemia and in need for
treatment.
The results of the study showed that boy’s number was
insigniﬁcantly higher than the girl’s number. The mean gesta-
tional age was 38.70 ± 1.38 weeks in FT compared to
35.62 ± 0.64 in PT. The mean birth weight was
3.302 ± 0.207 Kg in FT compared to 2.936 ± 0.207 Kg in PT
The mean TLC and neutrophil count were signiﬁcantly
higher among PT compared to FT. However there was no sta-
tistically signiﬁcant difference between PT and FT regarding
the mean albumin level and retics count.
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of transcutaneous bilirubin between FT and PT babies at any
time of measurement.
The peak level of transcutaneous bilirubin in either FT or
PT babies was on day 4 of life.
Regarding the needed treatment among study population,
it was found that 40.4% of PT and 29.8% of FT needed pho-
totherapy and no one of both groups needed exchange
transfusion.
ABO incompatibility was more common than RH incom-
patibility in all study population.
Total and direct cord bilirubin was slightly higher among
FT compared to PT. However these differences were not
signiﬁcant.
The cut off points for total cord bilirubin in PT and FT was
2.05 and 2.15 mg/dl respectively.
The strongest predictor of receiving phototherapy was total
cord bilirubin compared to gestational age, ABO, incompati-
bility, RH incompatibility and sex.
The study concluded that the total serum bilirubin in cord
blood was indicative of jaundice severity developed by healthy
FT and late PT without complications, during the ﬁrst week of
life. Levels that were equal to or greater than 2.05 mg/dl and
2.15 in PT and FT respectively indicate the need for further
treatment by phototherapy. In addition, it was also concluded
that the presence of mother/baby blood group incompatibility
was statistically signiﬁcant for the occurrence of high total
cord bilirubin that was indicative for phototherapy treatment.
Recommendations
(1) Cord blood bilirubin could be used as an indicator of
risk of icterus in newborns.
(2) The use of the cut-off cord bilirubin levels of 2.05 mg/dl
and 2.15 mg/dl in all healthy late pre-term and full-term
newborns respectively could be a useful predictor of sig-
niﬁcant hyperbilirubinemia that will need phototherapy
and avoid the risk of severe hyperbilirubinemia that may
need exchange transfusion.
(3) Transcutaneous bilirubinometry in the 4th day of life
could be used as a screening test to all the same time
with screening for hypothyroidism for early detection
of severe hyperbilirubinemia.
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